Kyocera stock remains a "Buy" after a big 3QFY26 beat and raised FY26 guidance. Here's what investors need to know.
Zacks.com on MSN
Here's Why You Should Add Masimo Stock to Your Portfolio Now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...
Idaho Strategic Resources (IDR) operates a cash-generating high-grade gold mine and holds an unproven strategic minerals portfolio, creating a two-engine business model.
In 2025, the zinc industry embraced a new phase of comprehensive development. Domestically, resource security continued to strengthen, smelting technology achieved breakthroughs and upgrades, and ...
Biggs Cardosa Associates, Inc. was contracted by the City of Corona for the McKinley Street Grade Separation project, which was a groundbreaking achievement as California's first vehicular steel ...
PlanetF1 on MSN
Michael Schumacher accident: Separating facts from fiction
Here are the known facts about Michael Schumacher's life and recovery from the severe injuries he suffered in a skiing ...
Construction and renovation projects generate massive amounts of waste, much of which may still hold material value. Concrete, asphalt, wood and metals often le ...
Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial. This is an ASCO Meeting ...
According to Towards Chemical and Materials, the global carbon capture utilization chemicals market volume was valued at ...
We begin our New York Giants position unit reviews by looking at all the players who suited up for the team at a position group, their impact, and where the position group stands as we head into the ...
Scientists at the U.S. Naval Research Laboratory are developing the next generation of solid-fuel ramjet (SFRJ) propulsion, ...
A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results